Immune System Gene Braking Discovery Opens Doors to New Cancer Therapies
Immune System Gene Braking Discovery Opens Doors to New Cancer Therapies
Genetic Engineering and Biotechnology News—Alex Marson, MD, PhD, director of the Gladstone-UCSF Institute of Genomic Immunology, explains the implications of his lab's recent identification of gene networks that control the function of immune cells, known as regulatory T cells, for therapies against cancer and autoimmune diseases.
Gladstone Experts Autoimmune Diseases Genomic Immunology Marson Lab


